EUVIMEDEUVIMED entdecken
Crossref

Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents

Takuya Tonami, Rei Sato, Masataka Nakano, Miki Nakajima, Tatsuki Fukami

Drug Metabolism and Disposition · 2026-06 · 54 (6) · 100318

DOI: 10.1016/j.dmd.2026.100318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-06. Verfasst von Takuya Tonami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Alcohol Dehydrogenase, Solvents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Kanazawa University, Ministry of Education, Culture, Sports, Science and Technology, Mochida Memorial Foundation for Medical and Pharmaceutical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxyzine, an aliphatic alcohol, is metabolized to the carboxylic acid cetirizine via 2 sequential oxidation steps involving the formation of an aldehyde intermediate. The initial aldehyde formation is considered the rate-limiting step in cetirizine production and is suggested to be catalyzed by NAD+-dependent alcohol dehydrogenase (ADH), which oxidizes aliphatic alcohols. However, the specific ADH isoform(s) involved remain unidentified. Identifying these enzyme(s) is essential for understanding interindividual variability in drug pharmacokinetics, efficacy, and toxicity. The aim of this study was to identify the ADH isoforms responsible for catalyzing hydroxyzine aldehyde formation using recombinant human ADHs. Hydroxyzine aldehyde formation in the human liver S9 fraction was significantly higher when NAD+ was used as a cofactor than with NADP+ or NADPH, supporting the involvement of ADH. Among the recombinant hepatic human ADH isoforms (ADH1A, ADH1B, ADH1C, ADH4, and ADH5), all except ADH1A catalyzed hydroxyzine aldehyde formation. Furthermore, hydroxyzine aldehyde formation in human liver cytosol was significantly inhibited by 4-methylpyrazole, a specific inhibitor of ADH1, consistent with a predominant role for ADH1B and ADH1C. DMSO, used as the solvent for 4-methylpyrazole, strongly inhibited the hydroxyzine aldehyde formation, with IC50 values of 0.29% ± 0.056% for ADH1B and 0.06% ± 0.004% for ADH1C. Additional solvent screening revealed that even at a concentration of 0.5%, methanol and isopropanol also strongly inhibited ADH isoforms-excluding ADH5-when hydroxyzine or abacavir was used as the substrate. These findings highlight the potent inhibitory effects of DMSO and several other organic solvents on ADH activity. SIGNIFICANCE STATEMENT: Through the identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine aldehyde formation by recombinant human ADH, the study revealed that several common organic solvents strongly inhibit ADH1. This highlights the need to consider the unintended inhibitory effects of such solvents on ADH activity when solubilizing lipophilic compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DehydrogenaseSolventsHumansRecombinant ProteinsOxidation-ReductionIsoenzymesLiverFomepizoleCytosolEnzyme Inhibitors

Stichwörter der Autor:innen

Alcohol dehydrogenaseDimethyl sulfoxideHydroxyzineOrganic solvent

Substanzen

Alcohol DehydrogenaseRecombinant ProteinsSolventsIsoenzymesFomepizoleEnzyme Inhibitors

Autor:innen und Institutionen

  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.
  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan.
  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan. Electronic address: tatsuki@…

Förderung

  • Kanazawa University
  • Ministry of Education, Culture, Sports, Science and Technology
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research

Zitieren

APA

Tonami, T., Sato, R., Nakano, M., Nakajima, M., & Fukami, T. (2026). Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents. Drug Metabolism and Disposition, 54(6), 100318. https://doi.org/10.1016/j.dmd.2026.100318

Vancouver

Tonami T, Sato R, Nakano M, Nakajima M, Fukami T. Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents. Drug Metabolism and Disposition. 2026;54(6):100318. doi:10.1016/j.dmd.2026.100318

BibTeX
@article{Tonami2026,
  author = {Tonami, Takuya and Sato, Rei and Nakano, Masataka and Nakajima, Miki and Fukami, Tatsuki},
  title = {Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {6},
  pages = {100318},
  doi = {10.1016/j.dmd.2026.100318}
}
Kostenlos starten →